Jyong Biotech director files initial Form 3

Jyong Biotech Ltd. director Chi Pang-Chieh has filed a Form 3 as a reporting person for the company.

Accepted by SEC EDGAR 04/01/2026 - 02:56 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Jyong Biotech Ltd. director Chi Pang-Chieh has filed a Form 3 as a reporting person for the company. The filing shows no reportable transactions and no listed holdings, with transaction counts and share amounts all recorded as zero in this initial ownership statement.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Net buy/sell shares: 0 shares +2 more

5 metrics

Buy transactions 0 transactions Form 3 transactionSummary buyCount

Sell transactions 0 transactions Form 3 transactionSummary sellCount

Net buy/sell shares 0 shares Form 3 transactionSummary netBuySellShares

Holding entries 0 entries Form 3 transactionSummary holdingEntries

Derivative transactions 0 transactions Form 3 transactionSummary derivativeTransactionCount

Key Terms

Form 3, reportingPersons, director, transactionSummary

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "Chi Pang-Chieh""

director regulatory

""is_director": 1"

transactionSummary financial

""transactionSummary": { "buyCount": 0,"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Jyong Biotech (MENS) director Chi Pang-Chieh’s Form 3 show?

The Form 3 identifies Chi Pang-Chieh as a director and reporting person for Jyong Biotech Ltd. It reports no transactions and no listed holdings, with all transaction and share-count metrics recorded as zero in this initial ownership statement.

Are any trades or transactions reported in the MENS Form 3 filing?

No trades or transactions are reported. The transaction list is empty, and the transaction summary shows zero buy, sell, acquire, dispose, exercise, gift, tax-withholding, and restructuring events, with net buy/sell shares recorded as zero and direction noted as neutral.

Does the Jyong Biotech (MENS) Form 3 show any derivative positions?

The Form 3 derivative section is empty. The derivativeSummary array contains no entries, and derivativeTransactionCount in the transaction summary is zero, indicating no derivative securities or derivative transactions are reported in this initial statement for the director.

How many holdings are disclosed in this Jyong Biotech Form 3?

The filing shows no holdings. The transactionSummary field lists holdingEntries as zero, and there are no non-derivative or derivative positions detailed, indicating no reportable ownership positions are listed for the director in this initial filing snapshot.

What does net buy/sell direction indicate in the MENS Form 3 data?

Net buy/sell direction is labeled neutral with netBuySellShares at zero. This reflects that the Form 3 includes no reported insider purchases, sales, or other transaction types for the director during the period covered by this initial ownership report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chi Pang-Chieh

(Last) (First) (Middle)

23F-3, NO.95, SEC. 1, XINTAI 5TH RD.

(Street)

NEW TAIPEI CITY TAIWAN, PROVINCE OF CHINA 221

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
Jyong Biotech Ltd. [ MENS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Chi Pang-Chieh	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)